Tor Audun Klingen

473 citations
21 papers · 353 indexed · h-index 11
Topics
Breast Cancer Treatment Studies (8 papers)Breast Lesions and Carcinomas (7 papers)Cancer Cells and Metastasis (3 papers)

In The Last Decade

Tor Audun Klingen

18 papers receiving 345 citations

Peers

Tor Audun Klingen
Comparison fields: 5 of 52
  • Oncology 197
  • Pulmonary and Respiratory Medicine 134
  • Pathology and Forensic Medicine 95
  • Cancer Research 81
  • Immunology 66
Replace Yanjun Hou with:
Yanjun Hou United States
Amro Masarwah Finland
Jingming Ye China
Antonia Márquez Spain
S A Bartow United States
Amna Sheri United Kingdom
Takuho Okamura Japan
M. Rudas Austria
Marion Hädrich Switzerland
Milim Kim South Korea
Tor Audun Klingen relative to Yanjun Hou United States Yanjun Hou's profile →
Citations per field
00.5×3.3×
Yanjun Hou · 1×
Citations per year

Countries citing papers authored by Tor Audun Klingen

Since Specialization
Citations

This map shows the geographic impact of Tor Audun Klingen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tor Audun Klingen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tor Audun Klingen more than expected).

Fields of papers citing papers by Tor Audun Klingen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tor Audun Klingen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tor Audun Klingen. The network helps show where Tor Audun Klingen may publish in the future.

Co-authorship network of co-authors of Tor Audun Klingen

This figure shows the co-authorship network connecting the top 25 collaborators of Tor Audun Klingen. A scholar is included among the top collaborators of Tor Audun Klingen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tor Audun Klingen. Tor Audun Klingen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 13
5 4
6 4
7 10
8 23
9 54
10 22
11 8
12 16
13 11
14 23
15 21
16 2
17 21
18 41
19 77
20 0

About Tor Audun Klingen

Tor Audun Klingen is a scholar working on Cancer Research, Pathology and Forensic Medicine and Otorhinolaryngology, having authored 21 papers that have together received 353 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (7 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Oncology (197 citations), Cancer Research (81 citations) and Pathology and Forensic Medicine (95 citations). Tor Audun Klingen has collaborated with scholars based in Norway, Germany and United Kingdom. Frequent co-authors include Lars A. Akslen, Elisabeth Wik, Einar Vigeland, Solveig Hofvind, Per Skaane, Ying Chen, Ying Chen, Ying Chen, Turid Aas and Ingunn M. Stefansson. Their work appears in journals such as PLoS ONE, Scientific Reports and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026